|
Change
Text Size +
Change
Text Size -
|
Recent Publications
- Abe, Y; Muto, M; Nieda, M; Nakagawa, Y; Nicol, A; Kaneko, T; Goto, S; Yokogawa, K; and Suzuki, K. (2009) Clinical and immunological evaluation of zolendronate-activated Vgamma9Vdelta2 T cell-based immunotherapy for patients with multiple myeloma. Experimental Hematology 37(8):956-968
- Tokuyama, H; Hagi, T; Mattarollo, SR; Morley, J; Wang, Q; Fai-So, H; Moriyasu, F; Nieda, M; and Nicol, AJ. (2008) Vgamma9Vdelta2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs-Rituximab and trastuzumab. International Journal of Cancer 122(11), 2526-34
- Takahara, M; Miyai, M; Tomiyama, M; Mutou, M; Nicol, AJ; Nieda, M. (2008) Co-pulsing tumor antigen pulsed dendrictic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vy9yo T cell activation. Journal of Leukocyte Biology 83(3):742-54.
- Mattarollo, S; Kenna, T; Nieda, M; Nicol AJ.
(2007) Chemotherapy and Zoledronate sensitize solid
tumor cells to V?9Vd2 T cell
cytotoxicity. Cancer Immunology and Immunotherapy 56(8):1285-97
- Lickliter, JD; Cox, J; Lin, H; Nieda, M and
Nicol, AJ (2007) Small-molecule Bcl-2 inhibitors
sensitize
tumour cells to immune-mediated
destruction.
British Journal of Cancer 96(4):600-8.
- Mattarollo, SR; Kenna, T; Nieda, M and Nicol,
AJ (2006) “Chemotherapy
pre-treatment sensitizes solid tumor-derived targets to Va24+NKT cell-mediated
cytotoxicity” International Journal of Cancer 119(7):1630-7
- Lin, H; Nieda M; Hutton JF; Rozenkov V and
Nicol, AJ (2006) “Analysis
of the effect of different NKT cell subpopulations on the activation
of CD4 and CD8 T cells, NK cells and B cells” Experimental
Hematology 34(3): 289-295.
- Lin, H; Nieda M; Hutton JF; Rozenkov V and
Nicol, AJ (2006) “Comparative
gene expression analysis of NKT cell subpopulations” Journal
of Leukocyte Biology 80(1):164-73.
- Crough, T; Purdie, DM; Okai, M; Maksoud, A;
Nieda, M; and Nicol, AJ (2004) Modulation of human
Ca24+Vb11:
NKT cells by age, malignancy
and conventional anti-cancer therapies. British Journal of Cancer
91(11):1880-6.
- Crough, T; Nieda, M; Nicol, AJ (2004) Granulocyte
Colony-Stimulation Factor Suppresses a-Galactosyl
Ceramide Responsive Human Ca24+Vb11+
NIKT Cells and Causes Th2 Polarization. Journal of Immunology
173(8):4960-6.
- Lin, H; Nieda, M; Nicol, AJ (2004) Differential
proliferative response of NKT Cell subpopulations
to in-vitro stimulation in the
presence
of different cytokines. European Journal of Immunology. 34(10):2664-71.
- Nieda, M; Okai, M; Tazbirkova, A; Lin, H; Yamaura,
A; Ide, K; Abraham, R; Juji, T; Macfarlane, D;
and Nicol, AJ (2004) Therapeutic
activation
of Va24+Vß11+NKT cells in human subjects results in highly
co-ordinated secondary activation of acquired and innate immunity.
Blood 103(2):383-389.
- Tazbirkova, A; Maksoud, A; Horley, D; Okai,
M; Crough, T; Nicol AJ; (2003) Effects of leukapheresis
protocol, cell processing and
cryopreservation on the generation of monocyte-derived dendritic
cells for immune therapy
Cytotherapy 5 (1): 31-39
- Kashiwase, K; Kikuchi, A; Ando, Y; Nicol,
AJ; Porcelli, SA; Tokunaga, K; Omine, M; Satake,
M; Juji, T; Nieda,
M; and Yasuhiko Koezuka (2003).
The CD1d natural killer T-cell antigen presentation pathway is
highly conserved between humans and rhesus macaques.
Immunogenetics. 54:776-781
- Henderson, RD; Rajah, T; Nicol, AJ; Read,
SJ (2003) Posterior leukoencephalopathy following
intrathecal
chemotherapy with MRA-documented
vasospasm. Neurology.
60(2):326-8
- Clark, T; Nieda, M; Morton, AJ; Boyd, A; Bashford,
J; Durrant, S; Nicol, AJ.(2002) Donor derived
b2a2-specific T cells for immunotherapy
of CML Journal of Immunotherapy 25(6):469-75
- Okai, M; Nieda, M; Tazbirkova, A; Horley,
D; Kikuchi, A; Durrant, S; Takahashi, T; Abraham,
R; Yagita,
H; Juji,T; Nicol, AJ.(2002)
Human peripheral blood Va24+Vß11+NKT cells expand following
administration of a-Galactosylceramide-pulsed dendritic cells
Vox sanguis 83(3):250-3.
- Lapteva, N; Nieda, M; Ando, Y; Nicol AJ; Ide,
K; Hatta-Ohashe, Y; Egawa, K, Juji, T; Tokunaga,
K.
(2001) Gene Expression Profiling
in Human Monocytes, Monocyte-derived Dendritic cells and ?-galactosylceramide-pulsed
Monocyte-derived Dendritic cells Biochemical and Biophysical
Research Communications ;289(2):531-8
- Kikuchi, A., Nieda M., Schmidt C., Koezuka,
Y., Ishihara, S., Ishikawa, Y., Tadokoro, K., Durrant,
S., Boyd, A., Juji, T., Nicol,
A. (2001)
In vitro anti-tumour activity of a-Galactosyl Ceramide stimulated
human invariant V?24NKT cells against melanoma British Journal
of
Cancer
Sep 1;85(5):741-6.
- Nieda, M., Nicol, AJ., Koezuka, Y., Kikuchi,
A., Lapteva, N.,Tanaka, Y., Tokunaga, K., Suzuki,
K.,
Kayagaki, N., Yagiat, H., Hirai, H. & Juji,
T. (2001) TRAIL expression by activated human CD4+ V-alpha 24+NKT
cells induces in vitro and in vivo apoptosis of human acute myeloid
leukaemia
cells. Blood 97 2067-74
- Nieda, M., Kikuchi, A., Nicol, A., Koezuka,
Y., Ando, Y., Ishihara, S., Lapteva, N., Yabe, T.,
Tokunaga,
K., Tadokoro K., & Juji
T. (2001) Dendritic cells rapidly undergo apoptosis in vitro
following culture with activated CD4+Va24 natural
killer T cells expressing
CD40L
Immunology 102 1-14
- Nicol, A., Nieda, M., Koezuka, Y., Porcelli,
S., Suzuki, K., Tadokoro, K., Durrant, S. & Juji,
T. (2000) Dendritic cells are targets for human invariant
V?24+ NKT cell cytototoxic activity -
an important
immune regulatory function. Experimental Hematology 28(3) 276-82
- Takahashi, T., Nieda, M., Koezuka, Y., Nicol,
A. J., Porcelli, S., Ishikawa, Y., Tadokoro, K.,
Hirai,
H. & Juji, T. (2000) Analysis
of human V?24+ NKT cells activated by ?-glycolsylceramide-pulsed
monocyte derived dendritic cells. Journal of Immunology 164,
4458-4464
- Nicol, A. J., Nieda, M., Koezuka, Y., Porcelli,
S., Suzuki, K., Tadokoro, K., Durrant, S. & Juji,
T. (2000) Human invariant V?24+ NKT cells activated
by ?-GalactosylCeramide(KRN7000) have cytotoxic
antitumour activity through mechanisms distinct from T cells
and
NK cells. Immunology, 99, 229
- Nieda, M., Nicol, A., Koezuka, Y., Kikuchi,
A., Takahashi, T., Nakamura, H., Furukawa, H., Yabe,
T., Ishikawa, Y., Tadokoro, K. & Juji,
T. (1999) Activation of human V?24NKT cells by ?-glycosylceramide
in a CD1d-restricted and V?24TCR-mediated manner. Human Immunology,
60,
10-19.
- Denning-Kendall, P A., Nicol, A. J., Horsley,
H., Donaldson, C., Bradley, B. & Hows, J. M.
(1998) Is in vitro expansion of human cord blood
cells clinically relevant? Bone Marrow Transplantation,
21, 225-232.
- Denning-Kendall, P.A., Horsley, H., Nicol,
A., Nieda, M., Bradley, B. & Hows, J. M. (1998)
Clinical application of in vitro expansion of cord
blood. Bone Marrow Transplantation, 22, S63-S65.
- Nieda, M., Nicol, A., Kikuchi, A., Kashiwase,
K., Taylor, K., Suzuki, K., Tadokoro, K. & Juji,
T. (1998) Dendritic cells stimulate the expansion
of bcr-abl specific CD8+ T cells with cytotoxic activity
against leukemic cells from patients with chronic myeloid leukemia.
Blood, 91, 977-983.
- Denning-Kendall, P., Donaldson, C., Nicol,
A. J., Bradley, B. A. & Hows,
J. M. (1996) Optimization of red cell depletion of cord blood
for banking. Experimental Hematology, 24, 1394-1401.
- Donaldson, C., Armitage, W. J., Denning-Kendall,
P. A., Nicol, A. J., Bradley, B. A. & Hows,
J. M. (1996) Optimal cryopreservation of human
umbilical cord blood (UCB). Bone Marrow Transplantation,
18, 725-731.
- Hows, J., Nicol, A., Denning-Kendall, P.,
Donaldson, C., Nieda, M. & Bradley, B. (1996)
Cord Blood as an alternate source of haemopoietic
stem cells. Annals of Oncology, 7, 47-51.
- Nieda, M., Nicol, A. J., Denning-Kendall,
P. A., Sweetenham, J., Bradley, B. & Hows, J.
M. (1996) Endothelial cells derived from CD34+ human
umbilical cord blood cells support hematopoiesis.
British
Journal of Haematology, 98, 775-777.
- Nicol, A. J., Nieda, M., Donaldson, C., Denning-Kendall,
P. A., Bradley, B. & Hows, J. (1995) Analysis
of cord blood CD34+ cells purified after cryopreservation.
Experimental Hematology, 23, 1589-1594.
- Donaldson, C., Denning-Kendall,
P., Nicol, A. J., Laundy, G., Hows, J. & Bradley,
B. (1994) Human Cord Blood Banking: An Alternative
to Unrelated Marrow Donor Registries? European Foundation
for Immunogenetics
Newsletter, 20-21.
|